MX2009005632A - Complemento nutricional. - Google Patents
Complemento nutricional.Info
- Publication number
- MX2009005632A MX2009005632A MX2009005632A MX2009005632A MX2009005632A MX 2009005632 A MX2009005632 A MX 2009005632A MX 2009005632 A MX2009005632 A MX 2009005632A MX 2009005632 A MX2009005632 A MX 2009005632A MX 2009005632 A MX2009005632 A MX 2009005632A
- Authority
- MX
- Mexico
- Prior art keywords
- nutritional supplement
- treatment
- found
- calcium
- bony
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title abstract 5
- 241000251468 Actinopterygii Species 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 206010006956 Calcium deficiency Diseases 0.000 abstract 1
- 201000005569 Gout Diseases 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 208000000913 Kidney Calculi Diseases 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010061291 Mineral deficiency Diseases 0.000 abstract 1
- 206010029148 Nephrolithiasis Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se ha encontrado un complemento nutricional derivado del tejido esquelético que se encuentra en peces cartilaginosos y con huesos, para ser útil en el tratamiento de deficiencias minerales, en particular la deficiencia por calcio, y adicionalmente en el tratamiento de artritis, cálculos renales, y gota en animales, incluyendo los humanos. También se proporciona una composición de un complemento nutricional y una composición farmacéutica que contiene el complemento nutricional. El complemento nutricional contiene de 300,000 a 400,000 mg/kg de calcio, 100 a 150 mg/kg de fósforo, 10 a 20 mg/kg de magnesio, y 1,500 a 2,000 mg/kg de sodio.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006906674A AU2006906674A0 (en) | 2006-11-29 | Composition food supplement for the treatment of patients suffering from kidney stone, gout & arthritis | |
| AU2007201520A AU2007201520A1 (en) | 2006-11-29 | 2007-04-05 | Comosition for the treatment of patients with kidney stones, gout - and arthritis |
| PCT/AU2007/001825 WO2008064411A1 (en) | 2006-11-29 | 2007-11-28 | Nutritional supplement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009005632A true MX2009005632A (es) | 2009-08-07 |
Family
ID=39467346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009005632A MX2009005632A (es) | 2006-11-29 | 2007-11-28 | Complemento nutricional. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100028455A1 (es) |
| EP (1) | EP2083836A4 (es) |
| JP (1) | JP2010510779A (es) |
| KR (1) | KR20100014284A (es) |
| AU (2) | AU2007201520A1 (es) |
| CA (1) | CA2669343A1 (es) |
| MX (1) | MX2009005632A (es) |
| RU (1) | RU2009119924A (es) |
| WO (1) | WO2008064411A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITTO20110577A1 (it) * | 2011-06-30 | 2012-12-31 | Stmicroelectronics Malta Ltd | Incapsulamento per un sensore mems e relativo procedimento di fabbricazione |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6028118A (en) * | 1996-08-08 | 2000-02-22 | Les Laboratoires Aeterna Inc. | Methods of using extracts of shark cartilage |
| US7504115B2 (en) * | 2002-02-15 | 2009-03-17 | Ocean Nutrition Canada Limited | Shark cartilage extracts and use thereof for immunomodulation |
| TW200423951A (en) * | 2002-11-13 | 2004-11-16 | Ming-Chung Wong | Method of preparing anti-angiogenic drug from cartilage and chondrocytes and methods of use |
| JP2005198557A (ja) * | 2004-01-15 | 2005-07-28 | Sanshii Foods:Kk | 蛋白質とコンドロイチン硫酸を含有する食品原料及びその製造方法 |
-
2007
- 2007-04-05 AU AU2007201520A patent/AU2007201520A1/en not_active Abandoned
- 2007-11-28 KR KR1020097013230A patent/KR20100014284A/ko not_active Withdrawn
- 2007-11-28 AU AU2007327558A patent/AU2007327558A1/en not_active Abandoned
- 2007-11-28 EP EP07845315A patent/EP2083836A4/en not_active Withdrawn
- 2007-11-28 US US12/516,639 patent/US20100028455A1/en not_active Abandoned
- 2007-11-28 WO PCT/AU2007/001825 patent/WO2008064411A1/en not_active Ceased
- 2007-11-28 MX MX2009005632A patent/MX2009005632A/es not_active Application Discontinuation
- 2007-11-28 JP JP2009538552A patent/JP2010510779A/ja active Pending
- 2007-11-28 RU RU2009119924/15A patent/RU2009119924A/ru not_active Application Discontinuation
- 2007-11-28 CA CA002669343A patent/CA2669343A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2669343A1 (en) | 2008-06-05 |
| RU2009119924A (ru) | 2011-01-10 |
| AU2007327558A1 (en) | 2008-06-05 |
| EP2083836A1 (en) | 2009-08-05 |
| EP2083836A4 (en) | 2011-03-02 |
| AU2007201520A1 (en) | 2008-06-12 |
| JP2010510779A (ja) | 2010-04-08 |
| WO2008064411A1 (en) | 2008-06-05 |
| KR20100014284A (ko) | 2010-02-10 |
| US20100028455A1 (en) | 2010-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE329587T1 (de) | Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen | |
| MX2007006254A (es) | Complejos de fosfato de calcio estabilizados. | |
| TW200628428A (en) | High calcium fertilizer composition | |
| MX2009005460A (es) | (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano. | |
| IL164370A0 (en) | Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease | |
| RU2008118101A (ru) | Смесь солей железа и меди, маскирующая металлический вкус | |
| SG178975A1 (en) | Indenone derivative and pharmaceutical composition comprising same | |
| TW200603746A (en) | Iron sulfate based phosphate adsorbent | |
| CA2534577A1 (en) | Method for promoting bone growth | |
| GB2451196A (en) | Compositions and methods for promoting the healing of tissue of multicellular organisms | |
| KR20170065851A (ko) | 천연 광물질을 이용한 미네랄복합체의 효율적인 제조방법 | |
| ES2192136A1 (es) | Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis. | |
| MX2009005632A (es) | Complemento nutricional. | |
| PL1863495T3 (pl) | Sól wapniowa 1,6:2,3:4,5-tripirofosforanu mioinozytolu jako efektor allosteryczny hemoglobiny w leczeniu raka | |
| DE112006002212A5 (de) | Nahrungsmittelzusatz zur Versorgung mit Mineralstoffen | |
| MX2013007191A (es) | Metodos y composiciones para prevenir y tratar la osteoartritis. | |
| WO2011031166A3 (en) | Fish feed | |
| ITFI20030194A1 (it) | Composizione farmaceutiche effervescenti contenenti | |
| MX2007011826A (es) | Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas. | |
| TW200833708A (en) | Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture | |
| GB0406912D0 (en) | Pharmaceutical composition for prophylaxis or treatment of osteoporosis and method to prepare the same | |
| WO2005123130A3 (en) | Improved treatments of rheumatic and arthritic diseases comprising combinations of a 5-lipoxygenase inhibitor | |
| WO2007044321A3 (en) | Latent procytotoxins and uses thereof | |
| WO2004026245A8 (en) | Substituted phosphonate compounds having bone anabolic activity | |
| TW200628168A (en) | Use of organic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |